Weight loss drug shows promise for cancer patients on chemo
NCT ID NCT06998758
First seen Jan 05, 2026 · Last updated May 07, 2026 · Updated 21 times
Summary
This study tests whether megestrol acetate, a drug that boosts appetite, can prevent weight loss in people with locally advanced colorectal cancer who are receiving chemotherapy before surgery. About 60 adults will be randomly assigned to get either megestrol acetate or a placebo alongside their standard chemo. The goal is to see if the drug helps patients maintain weight, feel better, and tolerate treatment more easily.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WEIGHT LOSS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Sixth Affiliated Hospital of Sun-Yat sen University
RECRUITINGGuangzhou, Guangdong, 510065, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.